July 3, 2024


Photos courtesy of Dr Howard-Anderson left and Dr Morgan right graphic by Getty Images

Bye-bye, CLABSI. Hello, HOB.

Experts explain the CDC's new quality metric, hospital-onset bacteremia and fungemia (HOB), which will look more broadly at health care-associated infections.

'Fall-Free Fridays'

Weekly rounds with a catchy name helped one hospital reduce patient falls.

Administrative harms commonly affect hospitalists, hospital leaders

Although just 6% of health care professionals were familiar with the term 'administrative harm,' once given a definition, 85% said such harms contributed to patient harm at least somewhat, a study of hospitalists and hospital leaders found.

Clostridioides difficile order set increased appropriateness of testing, study finds

The smart order set, implemented in one health care system, put a hard stop on orders for Clostridioides difficile testing if patients admitted for more than four days had recently received laxatives or been treated or tested for C. difficile.

Faculty coaching for first-year residents appeared to help with burnout effects

A coaching program at one institution showed a significant benefit on goal-setting attitudes, professional fulfillment, and perceived program career support among burned-out residents, in addition to being associated with an overall lower rate of burnout among residents.

Coronavirus | FREE
Most ACP Hospitalist content is available exclusively to ACP Members. This article is free to the public.

Effects of remdesivir evaluated in new manufacturer-funded studies

One analysis showed that remdesivir reduced mortality in COVID-19 patients requiring oxygen, while another showed no improvement in outcomes, but also no adverse effects, of the drug in hospitalized COVID-19 patients with kidney damage.

Take a quiz about the June 26 issue!

Every week, ACP Hospitalist posts a question about the previous week's issue. See how well you remember what you've read compared to other readers.

Overtreatment from troponin testing

A reader responds to a recent article about high-sensitivity troponin with a personal story.